Print Page | Contact Us | Sign In | Register
HIV Information and Resources
Share |

NIH: Undectable=Untransmittable

UPDATES Oct 2019: Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

HHS Pediatric Antiretroviral Treatment Guidelines Updated

2019 Recommended Immunization Schedule for HIV Patients

Updates to Zoster Prevention Guidelines 

The pharmacist's role in Post Exposure Prophylaxis

Registration is Now Open for HIV-associated Comorbidities Workshop: Sept 19-20, 2019

 The NIH Office of AIDS Research (OAR) funds research on HIV-associated comorbidities, co-infections, and complications through multiple Institutes and Centers (ICs), with a focus on diseases that fall within each IC’s mission and HIV/AIDS related funding priorities. This workshop will foster discussion among experts from different fields and disciplines to share their perspectives and explore interrelationships among multiple comorbidities, in an effort to refine research priorities that aim to improve the health and well-being of people with HIV. This workshop is free and open to the public on a first-come, first-served basis. If you cannot attend in person, please consider participating by webcast (link will be provided closer to the date of the meeting). The plenary sessions of the workshop (not breakout sessions) will be videocasted, recorded, and archived. Register Now

HIV Drug Approval History

NYC focus on Women, May 2019

Federally approved HIV/AIDS medical practice guidelines August 2019

Download Adherence Tips for Patients

Updates to the HHS Adult and Adolescent Antiretroviral Treatment Guidelines Released 7.15.19

The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is pleased to announce the release of an updated version of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV.


Updated HHS Perinatal Antiretroviral Treatment Guidelines Released

The HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission (the Panel) is pleased to announce the release of the updated Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States.


FDA approves new HIV-1 medications


Payment Options for Post‐Exposure Prophylaxis Following Non‐Occupational Exposures Including Sexual Assault (nPEP) (July 2016)


PEP Bill Language A10724/S8129




PSSNY, 7 Executive Centre Drive, Suite 2, Albany, NY 12203 * 518-869-6595 *